hydroxyitraconazole has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, C; Brekken, RA; Chembukar, V; DeBerardinis, RJ; Do, QN; Fattah, FJ; Faubert, B; Gerber, DE; Kallem, RR; Kasiri, S; Kernstine, KH; Kim, J; Leff, RD; Lenkinski, RE; Padmanabhan, C; Pedrosa, I; Pelosof, L; Putnam, WC; Reznik, SI; Saltarski, JM; Skelton, R; Subramaniyan, I; Xi, Y; Yuan, Q | 1 |
1 trial(s) available for hydroxyitraconazole and Angiogenesis, Pathologic
Article | Year |
---|---|
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Biopsy; Carcinoma, Non-Small-Cell Lung; Female; Hedgehog Proteins; Humans; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Patched-1 Receptor; Zinc Finger Protein GLI1 | 2020 |